These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 16210092)

  • 21. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.
    Wolff L; Garin MT; Koller R; Bies J; Liao W; Malumbres M; Tessarollo L; Powell D; Perella C
    Oncogene; 2003 Dec; 22(58):9265-74. PubMed ID: 14681685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic therapy of cancer with 5-aza-2'-deoxycytidine (decitabine).
    Momparler RL
    Semin Oncol; 2005 Oct; 32(5):443-51. PubMed ID: 16210084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
    Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
    Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA methyltransferases as targets for cancer therapy.
    Ghoshal K; Bai S
    Drugs Today (Barc); 2007 Jun; 43(6):395-422. PubMed ID: 17612710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells.
    Zhu WG; Dai Z; Ding H; Srinivasan K; Hall J; Duan W; Villalona-Calero MA; Plass C; Otterson GA
    Oncogene; 2001 Nov; 20(53):7787-96. PubMed ID: 11753657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic targets in hematopoietic malignancies.
    Claus R; Lübbert M
    Oncogene; 2003 Sep; 22(42):6489-96. PubMed ID: 14528273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines.
    Bender CM; Pao MM; Jones PA
    Cancer Res; 1998 Jan; 58(1):95-101. PubMed ID: 9426064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic drug discovery: targeting DNA methyltransferases.
    Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
    J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decitabine and its role in the treatment of hematopoietic malignancies.
    Plimack ER; Kantarjian HM; Issa JP
    Leuk Lymphoma; 2007 Aug; 48(8):1472-81. PubMed ID: 17701577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA methylation and gene silencing in cancer.
    Baylin SB
    Nat Clin Pract Oncol; 2005 Dec; 2 Suppl 1():S4-11. PubMed ID: 16341240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methylation disturbances as novel therapeutic target in lung cancer: preclinical and clinical results.
    Digel W; Lübbert M
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):1-11. PubMed ID: 15886007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting DNA hypermethylation: Computational modeling of DNA demethylation treatment of acute myeloid leukemia.
    Przybilla J; Hopp L; Lübbert M; Loeffler M; Galle J
    Epigenetics; 2017; 12(10):886-896. PubMed ID: 28758855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The silence of the genes: epigenetic disturbances in haematopoietic malignancies.
    Hackanson B; Guo Y; Lübbert M
    Expert Opin Ther Targets; 2005 Feb; 9(1):45-61. PubMed ID: 15757481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reactivating the expression of methylation silenced genes in human cancer.
    Karpf AR; Jones DA
    Oncogene; 2002 Aug; 21(35):5496-503. PubMed ID: 12154410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of 5-aza-2'-deoxycytidine on proliferation, differentiation and p15/INK4b regulation of human hematopoietic progenitor cells.
    Guo Y; Engelhardt M; Wider D; Abdelkarim M; Lübbert M
    Leukemia; 2006 Jan; 20(1):115-21. PubMed ID: 16307025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-Aza-2'-deoxycytidine (decitabine) on human breast carcinoma cells.
    Hurtubise A; Momparler RL
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):618-25. PubMed ID: 16783580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
    Cowan LA; Talwar S; Yang AS
    Epigenomics; 2010 Feb; 2(1):71-86. PubMed ID: 22122748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA hypermethylation as a chemotherapy target.
    Ren J; Singh BN; Huang Q; Li Z; Gao Y; Mishra P; Hwa YL; Li J; Dowdy SC; Jiang SW
    Cell Signal; 2011 Jul; 23(7):1082-93. PubMed ID: 21345368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Global identification of genes regulated by estrogen signaling and demethylation in MCF-7 breast cancer cells.
    Putnik M; Zhao C; Gustafsson JÅ; Dahlman-Wright K
    Biochem Biophys Res Commun; 2012 Sep; 426(1):26-32. PubMed ID: 22902638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
    Momparler RL; Côté S; Eliopoulos N
    Leukemia; 1997 Mar; 11 Suppl 1():S1-6. PubMed ID: 9130684
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.